5 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 3 | 1 | Terminated 1 |
Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder Bryophyllum - Overactive Bladder, Urge Urinary Incontinence | Phase 2 / Phase 3 | Terminated | University of Zurich | 9 | 2014-05-01 | 2017-10-26 |
| ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) ELB245, Tolterodine - Overactive Bladder, Urinary Incontinence | Phase 2 | Terminated | elbion AG | 275 | 2007-02-01 | 2007-08-08 |
| Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity AV608 - Overactive Bladder Syndrome | Phase 2 | Terminated | Avera Pharmaceuticals | 62 | 2006-06-01 | 2008-02-25 |
| Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients GW679769 - Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder | Phase 2 | Terminated | GlaxoSmithKline | 1 | 2006-01-01 | 2015-04-17 |
| Effect of Pelvic Floor Muscle Training in Stroke Pelvic Floor Muscle training - Stroke, Urinary Incontinence | Phase 2 | Terminated | Glostrup University Hospital, Copenhagen | 60 | 1999-01-01 | 2010-05-26 |
Urinary Bladder, Overactive (4) · Urinary Incontinence, Urge (3) · Spinal Cord Injuries (1) · Stroke (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Lower Urinary Tract Symptoms (5) · Male Urogenital Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Urination Disorders (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Urological Manifestations (5) · Urinary Bladder Diseases (4) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Brain Diseases (1)
Tolterodine Tartrate (1) · casopitant (1)
Avera Pharmaceuticals (1) · GlaxoSmithKline (1) · Glostrup University Hospital, Copenhagen (1) · University of Zurich (1) · elbion AG (1)
Denmark (1) · Germany (1) · Netherlands (1) · Poland (1) · Sweden (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Joao Siffert, MD (1) · Linda Cardozo, MD FRCOG (1) · Martin Michel, Prof. (1) · Sigrid G Tibaek, MSc., Pt (1)
PMID 15014939, PMID 15791633, PMID 16673051, PMID 23218404, PMID 34988092